Abdullah A, Peeters A, de Courten M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract. 2010;89(3):309–19.

PubMed  Article  Google Scholar 

Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840–6.

CAS  PubMed  Article  Google Scholar 

Bragg F, Tang K, Guo Y, et al. Associations of general and central adiposity with incident diabetes in Chinese men and women. Diabetes Care. 2018;41(3):494.

PubMed  Article  Google Scholar 

Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments. Circulation. 2007;116(1):39–48.

PubMed  Article  Google Scholar 

Snijder MB, Dekker JM, Visser M, et al. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels. Diabetes Care. 2004;27(2):372.

PubMed  Article  Google Scholar 

Hoyer D, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY. Subcutaneous thigh fat area is unrelated to risk of type 2 diabetes in a prospective study of Japanese Americans. Diabetologia. 2011;54(11):2795–800.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Livingston EH. Lower body subcutaneous fat accumulation and diabetes mellitus risk. Surg Obes Relat Dis. 2006;2(3):362–8.

PubMed  Article  Google Scholar 

Owora AH. Commentary: diagnostic validity and clinical utility of HbA1c tests for type 2 diabetes mellitus. Curr Diabetes Rev. 2018;14(2):196–9.

PubMed  PubMed Central  Article  Google Scholar 

Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes (Lond). 2008;32(Suppl 3):S56-59.

Article  Google Scholar 

Moran A, Jacobs DR, Steinberger J, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48(10):2039.

CAS  PubMed  Article  Google Scholar 

Buchanan TA, Metzger BE, Freinkel N, Bergman RN. Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol. 1990;162(4):1008–14.

CAS  PubMed  Article  Google Scholar 

Lindheim SR, Buchanan TA, Duffy DM, et al. Original articlescomparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J Soc Gynecol Investig. 1994;1(2):150–4.

CAS  PubMed  Article  Google Scholar 

Shimokata H, Muller DC, Fleg JL, Sorkin J, Ziemba AW, Andres R. Age as independent determinant of glucose tolerance. Diabetes. 1991;40(1):44–51.

CAS  PubMed  Article  Google Scholar 

Uusitupa M, Khan TA, Viguiliouk E, et al. Prevention of type 2 diabetes by lifestyle changes: a systematic review and meta-analysis. Nutrients. 2019;11(11):2611.

CAS  PubMed Central  Article  Google Scholar 

Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ. Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Eur J Epidemiol. 2015;30(7):529–42.

PubMed  Article  Google Scholar 

Merlotti C, Morabito A, Ceriani V, Pontiroli AE. Prevention of type 2 diabetes in obese at-risk subjects: a systematic review and meta-analysis. Acta Diabetol. 2014;51(5):853–63.

CAS  PubMed  Article  Google Scholar 

Raben A, Vestentoft PS, Brand-Miller J, et al. The PREVIEW intervention study: results from a 3-year randomized 2 x 2 factorial multinational trial investigating the role of protein, glycaemic index and physical activity for prevention of type 2 diabetes. Diabetes Obes Metab. 2021;23(2):324–37.

CAS  PubMed  Article  Google Scholar 

Mayer VL, Vangeepuram N, Fei K, et al. Outcomes of a weight loss intervention to prevent diabetes among low-income residents of East Harlem. New York Health Educ Behav. 2019;46(6):1073–82.

PubMed  Article  Google Scholar 

Lindström J, Peltonen M, Eriksson JG, et al. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia. 2013;56(2):284–93.

PubMed  Article  Google Scholar 

Richelsen B, Tonstad S, Rössner S, et al. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study. Diabetes Care. 2007;30(1):27–32.

CAS  PubMed  Article  Google Scholar 

Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695–704.

CAS  PubMed  Article  Google Scholar 

le Roux CW, Astrup A, Fujioka K, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389(10077):1399–409.

PubMed  Article  CAS  Google Scholar 

Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.

CAS  PubMed  Article  Google Scholar 

Clamp LD, Hume DJ, Lambert EV, Kroff J. Enhanced insulin sensitivity in successful, long-term weight loss maintainers compared with matched controls with no weight loss history. Nutr Diabetes. 2017;7(6):e282–e282.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Haw JS, Galaviz KI, Straus AN, et al. Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med. 2017;177(12):1808–17.

PubMed  PubMed Central  Article  Google Scholar 

Mansoor N, Vinknes KJ, Veierød MB, Retterstøl K. Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials. Br J Nutr. 2016;115(3):466–79.

CAS  PubMed  Article  Google Scholar 

Parretti HM, Jebb SA, Johns DJ, Lewis AL, Christian-Brown AM, Aveyard P. Clinical effectiveness of very-low-energy diets in the management of weight loss: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2016;17(3):225–34.

CAS  PubMed  Article  Google Scholar 

Esposito K, Kastorini CM, Panagiotakos DB, Giugliano D. Mediterranean diet and weight loss: meta-analysis of randomized controlled trials. Metab Syndr Relat Disord. 2011;9(1):1–12.

PubMed  Article  Google Scholar 

Cui Y, Cai T, Zhou Z, et al. Health effects of alternate-day fasting in adults: a systematic review and meta-analysis. Frontiers in Nutrition. 2020;7.

Patikorn C, Roubal K, Veettil SK, et al. Intermittent fasting and obesity-related health outcomes: an umbrella review of meta-analyses of randomized clinical trials. JAMA Netw Open. 2021;4(12):e2139558–e2139558.

PubMed  PubMed Central  Article  Google Scholar 

Gadde KM, Martin CK, Berthoud HR, Heymsfield SB. Obesity: pathophysiology and management. journal of the american college of cardiology. 2018;71(1):69–84.

Barnosky AR, Hoddy KK, Unterman TG, Varady KA. Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: a review of human findings. Transl Res. 2014;164(4):302–11.

PubMed  Article  Google Scholar 

Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009;360(9):859–73.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Christensen P, Meinert Larsen T, Westerterp-Plantenga M, et al. Men and women respond differently to rapid weight loss: metabolic outcomes of a multi-centre intervention study after a low-energy diet in 2500 overweight, individuals with pre-diabetes (PREVIEW). Diabetes Obes Metab. 2018;20(12):2840–51.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.

CAS  PubMed  Article  Google Scholar 

Diabetes Prevention Program Research G, Knowler WC, Fowler SE, et al 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (London, England). 2009;374(9702):1677–1686.

Gadde KM, Atkins KD. The limits and challenges of antiobesity pharmacotherapy. Expert Opin Pharmacother. 2020;21(11):1319–28.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27(1):155–61.

CAS  PubMed  Article  Google Scholar 

Lachin JM, Christophi CA, Edelstein SL, et al. Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program. Diabetes. 2007;56(4):1153–9.

CAS  PubMed  Article  Google Scholar 

Allison DB, Heshka S. Toward an empirically derived typology of obese persons: derivation in a nonclinical sample. Int J Eat Disord. 1993;13(1):93–108.

CAS  PubMed  Article  Google Scholar 

Heo M, Faith MS, Mott JW, Gorman BS, Redden DT, Allison DB. Hierarchical linear models for the development of growth curves: an example with body mass index in overweight/obese adults. Stat Med. 2003;22(11):1911–42.

PubMed  Article